FTH1 and ischemia reperfusion injury: Silibinin targets FTH1, disrupts the NCOA4–FTH1 interaction, reduces ferroptosis-mediated cell death, and alleviates renal dysfunction, pathological damage, and inflammation in ischemia–reperfusion injury (IRI) AKI mice, effectively preventing ischemia–reperfusion-induced renal injury (96).